One of the most urgent questions patients ask me is, “Can the tumor be removed with surgery?” The answer is not based on the scan alone.
Cancer operability depends on three questions: Can the cancer be removed well enough to provide meaningful benefit? Can acceptable function be preserved? And is the patient fit enough to recover safely?
An “inoperable” opinion can feel final, but it may describe only the present situation.
Some tumors become operable after treatment, while others can be controlled with nonsurgical therapies.
A careful cancer surgery assessment is more useful than a rushed yes-or-no answer.
An operable cancer is one for which surgery is feasible and appropriate.
A resectable cancer is a tumor the team believes can be removed with an adequate margin while avoiding unacceptable harm.
These terms are often used as if they mean the same thing, but there is a practical difference:
| Term | What it means for the patient |
|---|---|
| Resectable | The tumor appears technically removable with an acceptable cancer operation. |
| Operable | Surgery is technically possible, likely to provide worthwhile benefit, and reasonably safe for this particular patient. |
| Borderline resectable | The tumor is close to or involves important structures, so treatment before surgery may improve the chance of complete removal. |
| Locally advanced or unresectable | The tumor cannot currently be removed safely or completely because of its local extent, although other treatment may shrink or control it. |
A resectable tumor may occur in a patient who is not fit for a major operation. Conversely, a fit patient may have a tumor that cannot be safely separated from vital structures. Cancer surgery eligibility considers both the disease and the person.
I usually explain cancer surgery decision-making as a sequence of seven assessments. Each answers a different question, and no single test makes the decision by itself.
A biopsy removes a sample for examination under a microscope, called histopathology. It identifies the cancer type, grade, and sometimes biomarkers that indicate how it may behave or respond to treatment.
Cancers in the same organ are not always treated alike. For example, stomach lymphoma and stomach adenocarcinoma require different plans.
Cancer staging describes the size and local extent of the primary tumor, nearby lymph-node involvement, and whether cancer has spread to distant organs.
Depending on the cancer, assessment may include contrast-enhanced CT, MRI, PET-CT, endoscopy, endoscopic ultrasound, or staging laparoscopy. Not every patient needs every test.
The purpose is to create an accurate map. Widespread distant disease often makes systemic treatment—treatment that travels through the body—more appropriate than a major operation.
However, stage IV cancer is not automatically inoperable. Selected patients with limited spread may benefit from local treatment within a multidisciplinary plan.
The surgical oncologist studies how the tumor relates to the surrounding anatomy. We ask:
Resectability is not simply whether a surgeon can reach the tumor. It means performing an oncologically sound operation while preserving as much safe function as possible.
Similar-sized tumors can behave differently. A slow-growing, localized tumor may suit surgery, while an aggressive cancer may have microscopic spread even when scans appear localized. Systemic therapy or radiation may then need to come first.
The best operation is not necessarily the earliest one; it is performed at the right point in the treatment sequence.
Before recommending surgery, I define its purpose: cure, reducing recurrence risk, preventing a complication, relieving symptoms, or obtaining tissue. The expected benefit must justify the risks.
Removing a visible tumor may not control disease elsewhere. Yet surgery can sometimes relieve obstruction or bleeding even when cure is not possible. Patients should understand what it can and cannot achieve.
We assess heart and lung function, kidney and liver health, diabetes, blood counts, nutrition, mobility, frailty, medicines, previous treatments, and daily functioning. An anesthesiologist may recommend more tests before a major procedure.
Age alone does not decide eligibility. An active older adult may tolerate surgery better than a younger person with serious health problems.
When possible, anemia, poor nutrition, diabetes, smoking, or low fitness can be addressed through prehabilitation—preparing the body physically and nutritionally before treatment.
Complex cases are best discussed by a multidisciplinary tumor board. In our Bengaluru practice, this may include surgical, medical, and radiation oncologists, radiologists, pathologists, and anesthesiologists.
The team produces a coordinated recommendation, but it does not replace the patient’s preferences. The options should still be discussed with the patient and family.
Yes, treatment before surgery can make some cancers easier—or occasionally possible—to remove, but this depends on the cancer type and its response.
Treatment given before the main operation is called neoadjuvant therapy. It may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, or hormone therapy.
The aim may be to:
The National Cancer Institute defines neoadjuvant therapy as treatment given first to shrink a tumor before the main treatment, which is usually surgery.
After treatment, we repeat imaging and reassess the patient’s fitness. The cancer may become resectable, remain borderline, or remain unresectable. Because response is not guaranteed, that uncertainty should be discussed beforehand.
No. Inoperable does not mean untreatable, and it does not mean that care has stopped. It means surgery is not currently the safest or most effective option.
Other options may include:
Some plans aim to make later surgery possible. Others focus on controlling the cancer, relieving symptoms, preventing complications, and protecting quality of life.
Ask your treating team why the cancer is considered inoperable. Is the limitation its anatomy, distant spread, your general health, or the balance between benefit and harm? Is the decision permanent, or will it be reconsidered after treatment?
These details matter more than the label itself.
| Myth | Fact |
|---|---|
| “If cancer is operable, surgery must happen immediately.” | Timely evaluation is important, but proper biopsy, staging, health optimization, and treatment sequencing can make surgery safer and more effective. |
| “Stage IV cancer can never be operated on.” | Surgery is not appropriate for most widespread cancers, but selected patients with limited metastatic disease may benefit from local treatment after multidisciplinary review. |
| “A bigger operation gives better cancer control.” | The goal is adequate cancer removal with safe margins—not removing more tissue than necessary. |
| “Robotic surgery can make any tumor operable.” | Robotic, laparoscopic, thoracoscopic, and open surgery are different approaches. None can overcome unfavorable cancer biology or anatomy by itself. |
| “One surgeon’s opinion is the final answer.” | Borderline or complex cases may benefit from specialist review, updated imaging, and a multidisciplinary second opinion. |
Families often focus on tumor size, but location and behavior may matter more. A small tumor around a critical artery can be harder to remove than a larger tumor that remains well separated from nearby structures.
I also advise patients not to judge a plan by whether surgery comes first. For several cancers, chemotherapy or radiation before surgery is the planned, evidence-based route. Beginning with another treatment does not necessarily mean that the opportunity for surgery has been lost.
Ask for the reasoning behind the recommendation. A good cancer surgery plan explains:
A second opinion is reasonable when the case is complex, the proposed surgery is extensive, or the explanation remains unclear.
No. Operability means surgery is feasible and worthwhile; it does not guarantee cure. The outcome also depends on the cancer’s stage and biology, lymph-node involvement, surgical margins, treatment response, and whether additional therapy is required.
Scans provide the best preoperative map but cannot show every microscopic detail. Unexpected spread or involvement of a vital structure is sometimes found during surgery, so ask your surgeon about the backup plan.
Yes, some tumors become resectable after treatment. Reassessment considers the cancer type, response to treatment, updated imaging, and patient fitness.
No. Its location, involvement of nearby structures, presence of distant spread, and biological behavior may matter more than size alone.
Not always. Regional lymph nodes are treated with surgery or combined therapy in several cancers. Their number and location, along with the cancer type, influence the plan.
Sometimes. Selected patients with limited spread may receive surgery or another local treatment. Surgery may also relieve blockage or bleeding, but it does not benefit every person with metastatic cancer.
The approach depends on the tumor’s location and extent, previous treatment, patient health, and surgeon expertise. Minimally invasive surgery may aid recovery in selected patients; open surgery may be safer for others.
Consider one when a tumor is described as borderline or inoperable, the proposed operation is extensive, different teams recommend conflicting plans, or the reasoning remains unclear. Bring your biopsy results, scan images, and treatment records.
The decision to operate is a judgment about cancer biology, anatomy, treatment sequence, surgical risk, expected benefit, and the patient’s priorities.
If your cancer is operable, ask what surgery is expected to achieve and whether treatment should come first. If it is inoperable, ask why, what alternatives are available, and whether reassessment is planned.
Online information can help you prepare, but individualized medical advice requires a cancer team to review your complete records and discuss the options with you personally.
Written by: Dr. Suraj Manjunath
Senior Consultant Surgical Oncologist, Bangalore
MBBS, MS, MCh – Surgical Oncology
25+ years of experience in surgical oncology
12,000+ cancer surgeries performed
20,000+ patients treated
Former Professor and HOD, Surgical Oncology
This article has been written and medically reviewed under the guidance of Dr. Suraj Manjunath, Senior Surgical Oncologist in Bangalore. Dr. Suraj Manjunath has over 25 years of experience in the surgical treatment of cancers involving the gastrointestinal tract, breast, gynecological organs, head and neck region, thoracic organs, urologic system, endocrine glands, soft tissue, and bone.
He has extensive experience in open cancer surgery, robotic cancer surgery, laparoscopic cancer surgery, thoracoscopic cancer surgery, cytoreductive surgery, and HIPEC. His clinical focus is on safe cancer clearance, individualized surgical planning, complication prevention, and structured recovery after major cancer operations.
The content is intended for patient education and should not replace a personalized consultation with a qualified surgical oncologist.
Medically reviewed by: Dr. Suraj Manjunath
Senior Consultant Surgical Oncologist, Bangalore
Date Published:
Date Reviewed: